North China Pharmaceutical Company Ltd. provided earnings guidance for the year 2015. For the year, the company predicts a year-on-year increase of about 50% in the net profit belonging to shareholders of the listed company in 2015 and an increase of about 60% compared with the data (unaudited) after the retroactive adjustment in the same period in the year before.